Dosimetry results of Oncolym™ in the treatment of refractory B-cell non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Verkh, LI
Murray, JL
Kripas, CJ
Wessels, BW
Varma, VM
Kahn, D
Bushnell, DL
Serafini, AN
Oliver, JC
机构：
[1] Alpha Therapeut Corp, Los Angeles, CA 90032 USA
[2] MD Anderson, Houston, TX USA
[3] Cornell Univ, Ithaca, NY 14853 USA
[4] George Washington Med Ctr, Washington, DC USA
[5] Iowa City Vet Adm, Iowa City, IA USA
[6] Univ Miami, Miami, FL 33152 USA
来源：
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 1998年 / 13卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
49
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [31] HCV and HGV in B-cell non-Hodgkin's lymphoma
    Ellenrieder, V
    Weidenbach, H
    Frickhofen, N
    Michel, D
    Prümmer, O
    Klatt, S
    Bernas, O
    Mertens, T
    Adler, G
    Beckh, K
    JOURNAL OF HEPATOLOGY, 1998, 28 (01) : 34 - 39
  • [32] Rituximab for treatment of refractory insulin autoimmune syndrome associated with non-Hodgkin B-cell lymphoma
    Chen, Angela X.
    Beligaswatte, Ashanka
    White, Graham
    Burt, Morton G.
    CLINICAL ENDOCRINOLOGY, 2019, 91 (01) : 230 - 232
  • [33] Primary B-cell non-Hodgkin's lymphoma of the prostate
    Madhusudan, S
    John, LH
    Gillatt, D
    Price, CGA
    Pawade, J
    JOURNAL OF PATHOLOGY, 1999, 189 : 21A - 21A
  • [34] Antibody therapy of non-Hodgkin's B-cell lymphoma
    Chinn, P
    Braslawsky, G
    White, C
    Hanna, N
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (05) : 257 - 280
  • [35] Radioimmunotherapy for B-cell non-Hodgkin lymphoma
    Witzig, Thomas E.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (04) : 655 - 668
  • [36] STEM CELL TRANSPLANTATION FOR NON-HODGKIN'S LYMPHOMA (NHL)
    De Souza, Carmino
    LEUKEMIA RESEARCH, 2017, 61 : S11 - S12
  • [37] Lenalidomide response in relapsed/refractory diffuse large B-cell non-Hodgkin's lymphoma
    Lossos, Izidore S.
    Wiernik, Peter H.
    Justice, Glen
    Tuscano, Joseph M.
    Cole, Craig E.
    Vose, Julie M.
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Habermann, Thomas M.
    BLOOD, 2007, 110 (11) : 756A - 756A
  • [38] Phase I Results of Combination Gemcitabine and Bortezomib (Velcade®) for Relapsed/Refractory Nodal T-Cell Non-Hodgkin Lymphoma (T-NHL) and Aggressive B-Cell NHL (B-NHL)
    Evens, Andrew M.
    Gordon, Leo I.
    Patton, David
    Rosen, Steven T.
    Winter, Jane N.
    Kline, Justin
    Van Besien, Koen
    Smith, Sonali M.
    BLOOD, 2008, 112 (11) : 700 - 700
  • [39] Lisocabtagene maraleucel for relapsed or refractory large B-cell non-Hodgkin lymphoma
    Mohty, Razan
    Vanegas, Yenny Moreno
    Chavez, Julio C.
    Kharfan-Dabaja, Mohamed A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (02) : 121 - 126
  • [40] Axicabtagene ciloleucel for the treatment of relapsed/refractory B-cell non-Hodgkin's lymphomas
    Sharma, P.
    King, G. T.
    Shinde, S. S.
    Purev, E.
    Jimeno, A.
    DRUGS OF TODAY, 2018, 54 (03) : 187 - 198
12345